Opioid prescribing appears to be prevalent among older adults with rheumatic diseases, according to results presented at the American College of Rheumatology (ACR) Convergence 2025.
Treatment with sarilumab was associated with lower all-cause mortality compared with tocilizumab in adults with rheumatoid arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback